1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
605E38C2CAEC18E8285256D03006FFD78
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/managing-pharmaceutical-sales-force-incentives-for-high-performance?opendocument
18
19opendocument
2044.200.122.214
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Sales and Marketing » Sales Management » Managing Sales Force » Performance Management

Managing Pharmaceutical Sales Force Incentives for High Performance

DB Image

ID: 4405


Features:

Metrics, Graphics, Summary Matrix


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 15-slide PowerPoint presentation lays out the latest trends and thinking on whether to cap or uncap incentive pay from six leading global pharmaceutical companies. Featured are the exact mixes of incentive pay versus base salary and the common capping levels established. Also included are executive narratives about how to manage incentive pay, the pros and cons of capping and uncapping incentive pay and the various forms of special incentives used beyond standard bonus pay for consistently high performance. This research originated with the Best Practices, LLC Business Excellence Board (BEB.)

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Health Care


Companies Profiled:
AstraZeneca; Roche; Pfizer; Merck; Eli Lilly; GlaxoSmithK

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.